• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/18 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Patent holdings for IPC class C07D 211/18

Total number of patents in this class: 146

10-year publication summary

6
18
13
8
7
10
5
14
8
9
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Massachusetts Institute of Technology
10273
4
BioLegend, Inc.
82
4
The United States of America, as represented by the Secretary, Department of Health and Human Services
3007
4
Vividion Therapeutics, Inc.
44
4
F. Hoffmann-La Roche AG
7815
3
California Institute of Technology
4038
3
The Broad Institute, Inc.
1983
3
Council of Scientific & Industrial Research
1448
3
Research Triangle Institute
419
3
Richter Gedeon Nyrt.
1702
3
Taisho Pharmaceutical Co., Ltd.
850
3
Toyama Chemical Co., Ltd.
88
3
Atux Iskay LLC
11
3
Bristol-myers Squibb Company
4748
2
AstraZeneca AB
2824
2
Boehringer Ingelheim International GmbH
4483
2
Syngenta Crop Protection AG
6713
2
Bayer Pharma AG
1010
2
Agro-kanesho Co., Ltd.
51
2
Biophore India Pharmaceuticals Pvt. Ltd.
93
2
Other owners 89